Oral decitabine and cedazuridine for the treatment of myelodysplastic syndromes: an integrated review of clinical, economic and patient-centered evidence.
Saved in:
| Title: | Oral decitabine and cedazuridine for the treatment of myelodysplastic syndromes: an integrated review of clinical, economic and patient-centered evidence. |
|---|---|
| Authors: | Zeidan AM; Section of Hematology, Department of Internal Medicine, Yale School of Medicine and Yale Cancer Center, New Haven, CT, USA., Zhao R; Taiho Oncology, Inc, Princeton, NJ, USA., Epstein RS; Epstein Health, Woodcliff Lake, NJ, USA., Salimi T; Taiho Oncology, Inc, Princeton, NJ, USA. |
| Source: | Expert review of anticancer therapy [Expert Rev Anticancer Ther] 2025 Nov; Vol. 25 (11), pp. 1243-1250. Date of Electronic Publication: 2025 Aug 09. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Taylor & Francis Country of Publication: England NLM ID: 101123358 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1744-8328 (Electronic) Linking ISSN: 14737140 NLM ISO Abbreviation: Expert Rev Anticancer Ther Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 1744-8328 |
|---|---|
| DOI: | 10.1080/14737140.2025.2544859 |
